Lion Corporation (TYO:4912)
1,750.00
+27.50 (1.60%)
At close: Mar 6, 2026
Lion Corporation Revenue
In the year 2025, Lion Corporation had annual revenue of 422.09B JPY with 2.22% growth. Lion Corporation had revenue of 117.15B in the quarter ending December 31, 2025, with 4.80% growth.
Revenue
422.09B
Revenue Growth
+2.22%
P/S Ratio
1.15
Revenue / Employee
55.15M
Employees
7,654
Market Cap
484.14B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 422.09B | 9.15B | 2.22% |
| Dec 31, 2024 | 412.94B | 10.18B | 2.53% |
| Dec 31, 2023 | 402.77B | 12.90B | 3.31% |
| Dec 31, 2022 | 389.87B | 23.64B | 6.45% |
| Dec 31, 2021 | 366.23B | 10.88B | 3.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Paltac | 1.23T |
| Shiseido Company | 969.99B |
| Unicharm | 945.27B |
| Rohto Pharmaceutical | 335.80B |
| KOSE Holdings | 330.19B |
| Pola Orbis Holdings | 170.29B |
| Kobayashi Pharmaceutical | 165.74B |
| MTG Co., Ltd. | 109.56B |